What side effect should the nurse monitor in a client receiving steroid therapy for cancer treatment?

The focus of monitoring for clients receiving steroid therapy, particularly in the context of cancer treatment, includes being vigilant for hyperglycemia. Corticosteroids, commonly used in managing cancer therapy, can induce insulin resistance and elevate blood glucose levels. This effect can be particularly concerning in clients who may already be at risk for diabetes or those who have pre-existing diabetes, as it can lead to complications such as diabetic ketoacidosis or other serious metabolic issues if not managed effectively.

Clients on steroid therapy may experience other side effects such as mood changes, increased appetite, and fluid retention, but hyperglycemia is a significant metabolic effect that requires monitoring. The management of blood glucose levels is crucial to prevent potential complications and ensure safe continuity of treatment. Monitoring for hyperglycemia allows the healthcare team to provide timely interventions, such as insulin therapy or dietary modifications, to maintain glycemic control.